<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04984642</url>
  </required_header>
  <id_info>
    <org_study_id>2020-865</org_study_id>
    <nct_id>NCT04984642</nct_id>
  </id_info>
  <brief_title>Plasma, Urine and Tear Omics Changes in Different Diets</brief_title>
  <official_title>Plasma, Urine and Tear Omics Changes Based on Protein and Metabonomics Technology in Different Diets and Screening of Healthy Diet Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study plans to start in July 2021, and it is expected that 20 healthy people (aged 18-70&#xD;
      years old, BMI 18.5-40kg/m2) will carry out a 5-week intervention and follow-up. Participants&#xD;
      will be enrolled in the group through the screening and plan to take regular diet, OGTT,&#xD;
      high-fat diet, low-calorie diet and ketogenic diet within 5 weeks. The proteomics and&#xD;
      metabolomics indicators of tear, plasma, and urine specimens will be measured at 5 time&#xD;
      points at baseline, 30 minutes, 1 hour, 2 hours, and 3 hours for each diet. The correlation&#xD;
      of proteomics and metabolomics indicators with classic laboratory parameters (BMI, HDL, LDL,&#xD;
      cholesterol, triglyceride levels, and insulin resistance (HOMA-IR)) will be analyzed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proteomics and metabolomics changes after diet intervention</measure>
    <time_frame>5 weeks</time_frame>
    <description>Changes of plasma, urine, tear proteomics and metabolomics after diet intervention</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Diet, Healthy</condition>
  <arm_group>
    <arm_group_label>healty subject</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diet</intervention_name>
    <description>have OGTT,normal diet, high fat diet, low calorie diet, and ketogenic diet in turn</description>
    <arm_group_label>healty subject</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18-70 years old, BMI 18.5-40 kg/m2, fasting blood glucose within 7mmol/L; weight&#xD;
             fluctuation within 3 months does not exceed 5%;&#xD;
&#xD;
          2. The volunteers had no history of serious cardiovascular, liver, kidney, respiratory,&#xD;
             blood, endocrine, immune, neuropsychiatric and other diseases within 1 year, and were&#xD;
             in good general health at the time of enrollment;&#xD;
&#xD;
          3. Willing to accept a prescribed diet test every 3-9 days for 4 consecutive times, and&#xD;
             are willing to keep samples of blood, urine, feces, and tears;&#xD;
&#xD;
          4. Those who can communicate well with the investigator and understand and comply with&#xD;
             the requirements of this experiment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Active eating disorder; previous history of bariatric surgery;&#xD;
&#xD;
          2. Diabetes;&#xD;
&#xD;
          3. Those who have had serious gastrointestinal diseases in the past;&#xD;
&#xD;
          4. Diarrhea, nausea and vomiting in the past 2 weeks;&#xD;
&#xD;
          5. Patients with significant dysfunction of heart, liver, kidney, and systemic organs&#xD;
             (NYHA heart function grade â‰¥ II; ALT and/or AST increased to more than 5 times the&#xD;
             upper limit of normal; GFR &lt;30 ml/min), or malignant tumors Medical history&#xD;
&#xD;
          6. Those who have drug abuse or alcohol addiction;&#xD;
&#xD;
          7. Patients with severe mental or neurological diseases;&#xD;
&#xD;
          8. Pregnant women, breastfeeding women, or women who plan to give birth within the past&#xD;
             month;&#xD;
&#xD;
          9. Those who have special dietary requirements or have food allergies such as soy&#xD;
             products and dairy products;&#xD;
&#xD;
         10. Participating in other clinical trials.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pengfei Shan, MD</last_name>
    <phone>+86 13958039665</phone>
    <email>pengfeishan@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Second Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pengfei Shan, MD</last_name>
      <phone>+86 13958039665</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2021</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

